BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 25586069)

  • 1. Total synthesis of vinblastine, related natural products, and key analogues and development of inspired methodology suitable for the systematic study of their structure-function properties.
    Sears JE; Boger DL
    Acc Chem Res; 2015 Mar; 48(3):653-62. PubMed ID: 25586069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrapotent vinblastines in which added molecular complexity further disrupts the target tubulin dimer-dimer interface.
    Carney DW; Lukesh JC; Brody DM; Brütsch MM; Boger DL
    Proc Natl Acad Sci U S A; 2016 Aug; 113(35):9691-8. PubMed ID: 27512044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of a Potent Vinblastine: Rationally Designed Added Benign Complexity.
    Allemann O; Brutsch M; Lukesh JC; Brody DM; Boger DL
    J Am Chem Soc; 2016 Jul; 138(27):8376-9. PubMed ID: 27356080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.
    Lukesh JC; Carney DW; Dong H; Cross RM; Shukla V; Duncan KK; Yang S; Brody DM; Brütsch MM; Radakovic A; Boger DL
    J Med Chem; 2017 Sep; 60(17):7591-7604. PubMed ID: 28857558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-potent vinblastine analogues improve on-target activity of the parent microtubulin-targeting compound.
    Radakovic A; Boger DL
    Bioorg Med Chem Lett; 2019 Jun; 29(11):1370-1374. PubMed ID: 30952593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of vinblastine, vincristine, related natural products, and key structural analogues.
    Ishikawa H; Colby DA; Seto S; Va P; Tam A; Kakei H; Rayl TJ; Hwang I; Boger DL
    J Am Chem Soc; 2009 Apr; 131(13):4904-16. PubMed ID: 19292450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and SAR of vinca alkaloid analogues.
    Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tandem Intramolecular Diels-Alder/1,3-Dipolar Cycloaddition Cascade of 1,3,4-Oxadiazoles: Initial Scope and Applications.
    Sears JE; Boger DL
    Acc Chem Res; 2016 Feb; 49(2):241-51. PubMed ID: 26813287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.
    Wu ZC; Boger DL
    Nat Prod Rep; 2020 Nov; 37(11):1511-1531. PubMed ID: 33169762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A remarkable series of vinblastine analogues displaying enhanced activity and an unprecedented tubulin binding steric tolerance: C20' urea derivatives.
    Leggans EK; Duncan KK; Barker TJ; Schleicher KD; Boger DL
    J Med Chem; 2013 Feb; 56(3):628-39. PubMed ID: 23244701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of class III β-tubulin has no impact on functional cancer cell growth inhibition of a series of key vinblastine analogs.
    Radakovic A; Boger DL
    Bioorg Med Chem Lett; 2018 Mar; 28(5):863-865. PubMed ID: 29439899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Total synthesis and evaluation of a key series of C5-substituted vinblastine derivatives.
    Va P; Campbell EL; Robertson WM; Boger DL
    J Am Chem Soc; 2010 Jun; 132(24):8489-95. PubMed ID: 20518465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular docking and pharmacogenomics of vinca alkaloids and their monomeric precursors, vindoline and catharanthine.
    Sertel S; Fu Y; Zu Y; Rebacz B; Konkimalla B; Plinkert PK; Krämer A; Gertsch J; Efferth T
    Biochem Pharmacol; 2011 Mar; 81(6):723-35. PubMed ID: 21219884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modifications on the basic skeletons of vinblastine and vincristine.
    Keglevich P; Hazai L; Kalaus G; Szántay C
    Molecules; 2012 May; 17(5):5893-914. PubMed ID: 22609781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric total synthesis of vindorosine, vindoline, and key vinblastine analogues.
    Sasaki Y; Kato D; Boger DL
    J Am Chem Soc; 2010 Sep; 132(38):13533-44. PubMed ID: 20809620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical insight into the structural mechanism for the binding of vinblastine with tubulin.
    Chi S; Xie W; Zhang J; Xu S
    J Biomol Struct Dyn; 2015; 33(10):2234-54. PubMed ID: 25588192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign.
    Schleicher KD; Sasaki Y; Tam A; Kato D; Duncan KK; Boger DL
    J Med Chem; 2013 Jan; 56(2):483-95. PubMed ID: 23252481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reaction design, discovery, and development as a foundation to function-oriented synthesis.
    Micalizio GC; Hale SB
    Acc Chem Res; 2015 Mar; 48(3):663-73. PubMed ID: 25668752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Neurotrophic Activity Studies of Illicium Sesquiterpene Natural Product Analogues.
    Richers J; Pöthig A; Herdtweck E; Sippel C; Hausch F; Tiefenbacher K
    Chemistry; 2017 Mar; 23(13):3178-3183. PubMed ID: 28067432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
    Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
    Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.